AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AbbVie Inc. Director's Dealing 2024

Feb 6, 2024

29755_dirs_2024-02-06_5a98d1c6-728b-4e64-94a7-a1636041d17f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2024-02-02

Reporting Person: Siatis Perry C (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-02-02	Common Stock, $0.01 par value	A	2919	$144.54	Acquired	13296	Direct
2024-02-02	Common Stock, $0.01 par value	D	2919	$170	Disposed	10377	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-02	Option (Right to buy)	$144.54	M	2919	Disposed	2032-02-16	Common Stock (2919)	Direct

Footnotes

F1: This sale was executed pursuant to a Rule 10b5-1 plan that was entered into by the Reporting Person on February 14, 2023.

F2: Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.